Methylglyoxal induces mitochondrial dysfunction and cell death in liver

Area of Science:

• Biochemistry
• Cell Biology
• Toxicology

Background:

• Hyperglycemia elevates glucose degradation, leading to harmful liver effects.
• Methylglyoxal (MGO) levels increase in diabetes and contribute to cellular damage.

Purpose of the Study:

• To investigate MGO's role in mitochondrial dysfunction, apoptosis, and liver toxicity.
• To elucidate the mechanisms underlying MGO-induced cellular damage.

Main Methods:

• Experiments were conducted using HepG2 cells and in vivo mouse models.
• Assessed apoptosis, reactive oxygen species (ROS) production, glutathione (GSH) levels, and mitochondrial permeability transition.
• Measured liver enzymes alanine aminotransferase (ALT) and aspartate aminotransferase (AST) in plasma.

Main Results:

• MGO induced significant apoptotic cell death in HepG2 cells.
• MGO increased ROS production and depleted GSH, with antioxidants reducing apoptosis.
• MGO triggered mitochondrial permeability transition, indicating impairment, partially inhibited by cyclosporin A.
• MGO treatment elevated ALT and AST levels in mice, signifying liver toxicity.

Conclusions:

• MGO induces cell death and liver toxicity through ROS-mediated mitochondrial dysfunction.
• Oxidative stress is a key mechanism in MGO-induced hepatotoxicity.
• MGO is a significant contributor to diabetes-related liver complications.